PCN67 Erlotinib as Second Line Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC)- Economic Modeling (EM) results

Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1168
https://www.valueinhealthjournal.com/article/S1098-3015(11)02730-6/fulltext
Title : PCN67 Erlotinib as Second Line Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC)- Economic Modeling (EM) results
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02730-6&doi=10.1016/j.jval.2011.08.1168
First page : A446
Section Title : Cancer
Open access? : No
Section Order : 1125
Categories :
Tags :
Regions :
ViH Article Tags :